Defining the therapeutic potential of CD25 (IL2-R) blockade as a novel treatment for genetically stratified Crohn’s disease patients

Study code
NBR79

Lead researcher
Professor Graham Lord

Study type
Participant re-contact

Institution or company
King's College London

Researcher type
Non-commercial

Speciality area
Gastroenterology